Winkler G, Dittmann V, John U, Ladewig D
Department of Psychiatry, Medical University Lübeck, FRG.
Pharmacopsychiatry. 1990 Jun;23 Suppl 4:151-4. doi: 10.1055/s-2007-1014555.
The ICD-10 field trial of section F1 (mental and behavioural disorders due to psychoactive substance use) shows comparatively high acceptance of the new classification in German-speaking countries. Goodness of fit and subjective confidence of the main diagnosis are above average. Analysis of interrater reliability with regard to main diagnostic categories reveal certain problems. The reliability values are flow average within the ICD-10 field study. Possible causes for low interrater reliability are inadequate differentiation from section F0 (organic disorders) and uncertainties in the differential assessment of psychopathological symptoms between F1 and F2, as also between F1 and F4. Interrater reliability could be improved by introducing "psychoactive substance use" as a separate axis in a forthcoming multiaxial scheme for ICD-10.
国际疾病分类第十版（ICD - 10）中F1章节（精神活性物质所致精神和行为障碍）的现场试验表明，在德语国家，新分类的接受度相对较高。主要诊断的拟合优度和主观置信度高于平均水平。对主要诊断类别的评定者间信度分析揭示了一些问题。在ICD - 10现场研究中，信度值处于平均水平。评定者间信度较低的可能原因是与F0章节（器质性障碍）的区分不足，以及在F1与F2之间、F1与F4之间对精神病理症状进行鉴别评估时存在不确定性。通过在即将推出的ICD - 10多轴方案中引入“精神活性物质使用”作为一个单独轴，评定者间信度可能会得到提高。
